Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American ...

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

Vera Therapeutics, Inc.’s VERA share price has surged by 6.17%, which has investors questioning if this is right time to sell.

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 immune checkpoint blockade, enhancing immunogenic cell death and T cell ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 7.99%, which has investors questioning if this is right ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Proteins utilized in this study, detailed in Table 2, were expressed in CHO cells at WuXi Biologics (Shanghai ... pH and yield of Protein A chromatography with mAb A, mAb B and Fc Fusion. The left ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

But many components of the cell still remain uncharted. " We know each of the proteins that exist in our cells, but how they fit together to then carry out the function of a cell still remains ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...